Navigation Links
ResMed Inc. to Present at Upcoming Conferences in June
Date:5/27/2009

SAN DIEGO, May 27 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that it will be presenting at three upcoming conferences. David Pendarvis, SVP Organization Development and General Counsel will present at the William Blair Growth Stock Conference at the Four Seasons in Chicago on June 10, 2009 at 9:20 a.m. US Central Time. Kieran Gallahue, President and CEO will present at the Jefferies Third Annual Healthcare Conference at the Mandarin Oriental in New York City on June 18, 2009 at 9:30 a.m. US Eastern Time. David Pendarvis, SVP Organization Development and General Counsel will present at the Wachovia/Wells Fargo Annual Mid-Year Equity Conference at the Intercontinental Boston Hotel in Boston on June 23, 2009 at 4:00 p.m. US Eastern Time.

The Company's presentations will be webcast. To access the live webcast or the archived webcast of the presentation, please log onto the Company's website at http://investor.resmed.com. Further information can be obtained by contacting Constance Bienfait at ResMed Inc., San Diego, at +1(858) 836-5971 or by visiting the Company's multilingual Web site at www.resmed.com.

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.


'/>"/>
SOURCE ResMed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ResMed Inc. to Present at Upcoming Healthcare Conferences in May
2. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results
3. ResMed Inc Announces Record Financial Results for the Quarter and Six Months Ended December 31, 2008
4. ResMed to Webcast Second Quarter 2009 Earnings Conference Call
5. ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008
6. ResMed to Webcast First Quarter 2009 Earnings Conference Call
7. ResMed to Webcast Third Quarter 2008 Earnings Conference Call
8. RESMED to Webcast Second Quarter 2008 Earnings Conference Call
9. ResMed to Webcast First Quarter 2008 Earnings Conference Call
10. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
11. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman ... law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at ... DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology Group ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software ... and employees that are both engaging and easy to use. Coming off the ... software company revealed today its plans to roll out new AI-powered self-service enhancements ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients ... With this in mind, SIGVARIS has created a new line of anti-embolism stockings ... rest and provide the benefits of graduated compression when transitioning from recovery to ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
(Date:12/8/2016)... 2016 Australia Glaucoma Surgery Devices Market ... report, "Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices market. The report provides value, ... and average prices (USD) within market segement - ... company shares and distribution shares data for each ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... to grow in 2017-2023. Various reasons for growth of ... population, higher incidences of chronic diseases, high recovery cost ... aid services. Medical lifting sling refers to an ... limited mobility. These slings connect to the lift and ...
Breaking Medicine Technology: